Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency

Amy W. Strilchuk, Scott C. Meixner, Jerry Leung, Nooshin S. Safikhan, Jayesh A. Kulkarni, Hannah M. Russell, Roy van der Meel, Michael R. Sutherland, A. Phillip Owens, III, Joseph S. Palumbo, Edward M. Conway, Edward L. G. Pryzdial, Pieter R. Cullis, Christian J. Kastrup

Blood (2020) 136 (25): 2946–2954.

https://doi.org/10.1182/blood.2020004976

Published: 2020

Includes: Supplemental data

Journal Articles

Covalent Stabilization Of Coagulation Factor Xa Enhances Its Fibrinolytic Function In Vitro and In Vivo : A Novel Cofactor-Based Thrombolytic Agent

Ed L.G. Pryzdial, Ph.D., Kimberley Talbot, MPhil, Scott C. Meixner, B.Sc., Louise J. Eltringham-Smith, MSc, William P Sheffield, Ph.D.

Blood (2013) 122 (21): 204.

https://doi.org/10.1182/blood.V122.21.204.204

Published: 2013

Journal Articles

Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway

Michael J. Krisinger, Verena Goebeler, Zhen Lu, Scott C. Meixner, Timothy Myles, Edward L. G. Pryzdial, Edward M. Conway

Blood (2012) 120 (8): 1717–1725.

https://doi.org/10.1182/blood-2012-02-412080

Published: 2012

Includes: Supplemental data

Journal Articles

Factor Xa-Antithrombin Complex Enhances Tissue Plasminogen Activator-Mediated Clot Lysis

Kimberley Talbot, Scott C. Meixner, Edward L.G. Pryzdial

Blood (2011) 118 (21): 1180.

https://doi.org/10.1182/blood.V118.21.1180.1180

Published: 2011

Journal Articles

Plasmin-Mediated Coagulation Factor Xa Derivative, Xa33/13, Enhances Plasminogen Activation and Fibrin Clot Lysis.

Ed L.G. Pryzdial, PhD, Kimberley Talbot, MS, Scott C. Meixner, BSc

Blood (2006) 108 (11): 1717.

https://doi.org/10.1182/blood.V108.11.1717.1717

Published: 2006

NARROW

Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency

Covalent Stabilization Of Coagulation Factor Xa Enhances Its Fibrinolytic Function In Vitro and In Vivo : A Novel Cofactor-Based Thrombolytic Agent

Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway

Factor Xa-Antithrombin Complex Enhances Tissue Plasminogen Activator-Mediated Clot Lysis

Plasmin-Mediated Coagulation Factor Xa Derivative, Xa33/13, Enhances Plasminogen Activation and Fibrin Clot Lysis.

Email alerts

ASH Publications

American Society of Hematology

Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency

Covalent Stabilization Of Coagulation Factor Xa Enhances Its Fibrinolytic Function In Vitro and In Vivo : A Novel Cofactor-Based Thrombolytic Agent

Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway

Factor Xa-Antithrombin Complex Enhances Tissue Plasminogen Activator-Mediated Clot Lysis

Plasmin-Mediated Coagulation Factor Xa Derivative, Xa33/13, Enhances Plasminogen Activation and Fibrin Clot Lysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only